Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA [human leukocyte antigen]-A 0201 in Treating Patients With Refractory Gastric Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gastric cancer vaccine; Gimeracil/oteracil/tegafur; Montanide ISA-51
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 20 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Nov 2009 Biomarkers information updated
- 05 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.